135 related articles for article (PubMed ID: 11257520)
1. Analysis of the physicochemical interactions between Clostridium difficile toxins and cholestyramine using liquid chromatography with post-column derivatization.
Palace GP; Lazari P; Norton K
Biochim Biophys Acta; 2001 Mar; 1546(1):171-84. PubMed ID: 11257520
[TBL] [Abstract][Full Text] [Related]
2. Binding of Clostridium difficile cytotoxin and vancomycin by anion-exchange resins.
Taylor NS; Bartlett JG
J Infect Dis; 1980 Jan; 141(1):92-7. PubMed ID: 7365273
[TBL] [Abstract][Full Text] [Related]
3. A Size-Exclusion Chromatography Method for Analysis of Clostridium difficile Vaccine Toxins.
Lancaster C; Rustandi RR; Pannizzo P; Ha S
Methods Mol Biol; 2016; 1476():279-87. PubMed ID: 27507349
[TBL] [Abstract][Full Text] [Related]
4. Ion-Exchange Chromatography to Analyze Components of a Clostridium difficile Vaccine.
Rustandi RR; Wang F; Lancaster C; Kristopeit A; Thiriot DS; Heinrichs JH
Methods Mol Biol; 2016; 1476():269-77. PubMed ID: 27507348
[TBL] [Abstract][Full Text] [Related]
5. Development of a dose assay for a Clostridium difficile vaccine using a tandem ion exchange high performance liquid chromatography method.
Wang F; Ha S; Rustandi RR
J Chromatogr A; 2017 May; 1498():163-168. PubMed ID: 28366569
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Clostridium sordellii toxins HT and LT with toxins A and B of C. difficile.
Martinez RD; Wilkins TD
J Med Microbiol; 1992 Jan; 36(1):30-6. PubMed ID: 1370542
[TBL] [Abstract][Full Text] [Related]
7. GT160-246, a toxin binding polymer for treatment of Clostridium difficile colitis.
Kurtz CB; Cannon EP; Brezzani A; Pitruzzello M; Dinardo C; Rinard E; Acheson DW; Fitzpatrick R; Kelly P; Shackett K; Papoulis AT; Goddard PJ; Barker RH; Palace GP; Klinger JD
Antimicrob Agents Chemother; 2001 Aug; 45(8):2340-7. PubMed ID: 11451694
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic-associated pseudomembranous colitis.
Amin NM
Am Fam Physician; 1985 May; 31(5):115-20. PubMed ID: 3993509
[TBL] [Abstract][Full Text] [Related]
9. Physical characterization of clostridium difficile toxins and toxoids: effect of the formaldehyde crosslinking on thermal stability.
Salnikova MS; Joshi SB; Rytting JH; Warny M; Middaugh CR
J Pharm Sci; 2008 Sep; 97(9):3735-52. PubMed ID: 18257030
[TBL] [Abstract][Full Text] [Related]
10. The role of anion-exchange resins in the treatment of antibiotic-associated pseudomembranous colitis.
Ariano RE; Zhanel GG; Harding GK
CMAJ; 1990 May; 142(10):1049-51. PubMed ID: 2186849
[No Abstract] [Full Text] [Related]
11. Anion-exchange resins in pseudomembranous colitis.
George RH; Youngs DJ; Johnson EM; Burdon DW
Lancet; 1978 Sep; 2(8090):624. PubMed ID: 80541
[No Abstract] [Full Text] [Related]
12. Toxin-binding treatment for Clostridium difficile: a review including reports of studies with tolevamer.
Weiss K
Int J Antimicrob Agents; 2009 Jan; 33(1):4-7. PubMed ID: 18804351
[TBL] [Abstract][Full Text] [Related]
13. Infection with Toxin A-Negative, Toxin B-Negative, Binary Toxin-Positive Clostridium difficile in a Young Patient with Ulcerative Colitis.
Androga GO; Hart J; Foster NF; Charles A; Forbes D; Riley TV
J Clin Microbiol; 2015 Nov; 53(11):3702-4. PubMed ID: 26354812
[TBL] [Abstract][Full Text] [Related]
14. Recognition of human milk oligosaccharides by bacterial exotoxins.
El-Hawiet A; Kitova EN; Klassen JS
Glycobiology; 2015 Aug; 25(8):845-54. PubMed ID: 25941008
[TBL] [Abstract][Full Text] [Related]
15. Antigenicity of amino-acid sequences from Clostridium difficile toxin B.
Torres JF; Monath TP
J Med Microbiol; 1996 Jun; 44(6):464-74. PubMed ID: 8636964
[TBL] [Abstract][Full Text] [Related]
16. Clinical and laboratory observations in Clostridium difficile colitis.
Bartlett JG; Taylor NS; Chang T; Dzink J
Am J Clin Nutr; 1980 Nov; 33(11 Suppl):2521-6. PubMed ID: 7435423
[No Abstract] [Full Text] [Related]
17. Structural characterization of the cell wall binding domains of Clostridium difficile toxins A and B; evidence that Ca2+ plays a role in toxin A cell surface association.
Demarest SJ; Salbato J; Elia M; Zhong J; Morrow T; Holland T; Kline K; Woodnutt G; Kimmel BE; Hansen G
J Mol Biol; 2005 Mar; 346(5):1197-206. PubMed ID: 15713474
[TBL] [Abstract][Full Text] [Related]
18. Clonal spread of a Clostridium difficile strain with a complete set of toxin A, toxin B, and binary toxin genes among Polish patients with Clostridium difficile-associated diarrhea.
Pituch H; Kreft D; Obuch-Woszczatynski P; Wultańska D; Meisel-Mikołajczyk F; Łuczak M; van Belkum A
J Clin Microbiol; 2005 Jan; 43(1):472-5. PubMed ID: 15635019
[TBL] [Abstract][Full Text] [Related]
19. Clostridium Difficile, Colitis, and Colonoscopy: Pediatric Perspective.
McConnie R; Kastl A
Curr Gastroenterol Rep; 2017 Aug; 19(8):34. PubMed ID: 28707191
[TBL] [Abstract][Full Text] [Related]
20. A non-haemagglutinating form of Clostridium difficile toxin A.
Kamiya S; Borriello SP
J Med Microbiol; 1992 Mar; 36(3):190-7. PubMed ID: 1548692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
